Stockreport

MyMD Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing

MyMD Pharmaceuticals, Inc.  (MYMD) 
PDF Common Stock Will Begin Trading on Split-Adjusted Basis on February 15, 2024 BALTIMORE--(BUSINESS WIRE)--MyMD Pharmaceuticals, Inc.® (Nasdaq: MYMD) (“MyMD” or “the Co [Read more]